Please enable JavaScript to continue using this application.

Compare $BMEA vs $CRBP | Chartloom

Compare

$BMEA vs $CRBP

Biomea Fusion Inc · Corbus Pharmaceuticals Holdings Inc

BMEA

Biomea Fusion Inc

CRBP

Corbus Pharmaceuticals Holdings Inc

Compare $BMEA vs $CRBP

Comparing Biomea Fusion Inc and Corbus Pharmaceuticals Holdings Inc

BMEABiomea Fusion Inc

CRBPCorbus Pharmaceuticals Holdings Inc

BMEABiomea Fusion Inc

Market cap

$103M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

6.0%

52W performance

-15.5%

FCF yield

-46.0%

CRBPCorbus Pharmaceuticals Holdings Inc

Market cap

$100M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-31.6%

52W performance

-59.9%

FCF yield

-87.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BMEA

CRBP

Detailed metrics comparison

BMEA

Biomea Fusion Inc

CRBP

Corbus Pharmaceuticals Holdings Inc

Market Cap

BMEA$103M

CRBP$100M

Enterprise Value

BMEA$68M

CRBP$76M

Price

BMEA$1.42

CRBP$5.38

P/E Ratio

BMEAN/A

CRBPN/A

P/S Ratio

BMEA0.00x

CRBP76.49x

EV/Sales

BMEA0.00x

CRBP61.41x

EV/EBITDA

BMEA0.00x

CRBP0.00x

P/B Ratio

BMEA7.58x

CRBP1.16x

P/FCF Ratio

BMEAN/A

CRBPN/A

EV/FCF

BMEA-1.44x

CRBP-0.88x

PEG Ratio

BMEAN/A

CRBPN/A

Forward P/E (NTM)

BMEAN/A

CRBPN/A

Forward P/S (NTM)

BMEAN/A

CRBPN/A

Revenue (TTM)

BMEA$0

CRBP$0

Revenue Growth (YoY)

BMEAN/A

CRBPN/A

Forward Rev Growth

BMEA-19.3%

CRBP116.0%

Gross Margin (TTM)

BMEA0.0%

CRBP0.0%

Operating Margin (TTM)

BMEA0.0%

CRBP0.0%

EBITDA Margin (TTM)

BMEA0.0%

CRBP0.0%

Net Margin (TTM)

BMEA0.0%

CRBP0.0%

FCF Margin (TTM)

BMEAN/A

CRBPN/A

Net Income (TTM)

BMEA$-33M

CRBP$-102M

FCF (TTM)

BMEA$-47M

CRBP$-87M

EPS (TTM)

BMEA-$0.45

CRBP-$5.25

ROE (TTM)

BMEA-17119.0%

CRBP-8705.0%

ROA (TTM)

BMEA-6606.0%

CRBP-7422.0%

ROIC (TTM)

BMEA-17119.0%

CRBP-8705.0%

Cash

BMEA$35M

CRBP$23M

Debt

BMEA$0

CRBP$0

Net Cash/Debt

BMEA$35M

CRBP$23M

Current Ratio (TTM)

BMEA3.48x

CRBP5.71x

Quick Ratio (TTM)

BMEA3.36x

CRBP5.62x

Debt/Equity (TTM)

BMEA0.00x

CRBP0.00x

Debt/Assets (TTM)

BMEA0.0%

CRBP0.0%

Interest Coverage (TTM)

BMEAN/A

CRBPN/A

Net Debt/EBITDA (TTM)

BMEA0.00x

CRBP0.00x

Beta

BMEA-0.24

CRBP2.74

52W Performance

BMEA-15.5%

CRBP-59.9%

YTD Performance

BMEA6.0%

CRBP-31.6%

% from 52W High

BMEA-36.5%

CRBP-73.8%

% from 52W Low

BMEA62.9%

CRBP4.9%

Asset Turnover (TTM)

BMEA0.00x

CRBP0.01x

FCF Yield (TTM)

BMEA-46.0%

CRBP-87.0%

Earnings Yield (TTM)

BMEA-31.7%

CRBP-102.2%

Dividend Yield (TTM)

BMEAN/A

CRBPN/A

Rule of 40

BMEA0.0

CRBP0.0

EV/GP/RG

BMEAN/A

CRBPN/A

Ticker research

View BMEA research View CRBP research

Metric	BMEA Biomea Fusion Inc	CRBP Corbus Pharmaceuticals Holdings Inc
Market & Valuation
Market Cap	$103M	$100M
Enterprise Value	$68M	$76M
Price	$1.42	$5.38
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	76.49x
EV/Sales	0.00x	61.41x
EV/EBITDA	0.00x	0.00x
P/B Ratio	7.58x	1.16x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.44x	-0.88x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	-19.3%	116.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-33M	$-102M
FCF (TTM)	$-47M	$-87M
EPS (TTM)	-$0.45	-$5.25
ROE (TTM)	-17119.0%	-8705.0%
ROA (TTM)	-6606.0%	-7422.0%
ROIC (TTM)	-17119.0%	-8705.0%
Financial Health
Cash	$35M	$23M
Debt	$0	$0
Net Cash/Debt	$35M	$23M
Current Ratio (TTM)	3.48x	5.71x
Quick Ratio (TTM)	3.36x	5.62x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.24	2.74
52W Performance	-15.5%	-59.9%
YTD Performance	6.0%	-31.6%
% from 52W High	-36.5%	-73.8%
% from 52W Low	62.9%	4.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-46.0%	-87.0%
Earnings Yield (TTM)	-31.7%	-102.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BMEA research	View CRBP research

Valuation

P/S Ratio

BMEA

0.00x

CRBP

76.49x

EV/FCF

BMEA

-1.44x

CRBP

-0.88x

Growth & revenue

Forward Revenue Growth

CRBP

116.0%

BMEA

-19.3%

Profitability & performance

Gross Margin

BMEA

0.0%

CRBP

0.0%

ROE

CRBP

-8705.0%

BMEA

-17119.0%

FCF Yield %

BMEA

-46.0%

CRBP

-87.0%

52-Week Performance

BMEA

-15.5%

CRBP

-59.9%

Detailed metrics comparison

BMEA

Biomea Fusion Inc

CRBP

Corbus Pharmaceuticals Holdings Inc

Market Cap

BMEA$103M

CRBP$100M

Enterprise Value

BMEA$68M

CRBP$76M

Price

BMEA$1.42

CRBP$5.38

P/E Ratio

BMEAN/A

CRBPN/A

P/S Ratio

BMEA0.00x

CRBP76.49x

EV/Sales

BMEA0.00x

CRBP61.41x

EV/EBITDA

BMEA0.00x

CRBP0.00x

P/B Ratio

BMEA7.58x

CRBP1.16x

P/FCF Ratio

BMEAN/A

CRBPN/A

EV/FCF

BMEA-1.44x

CRBP-0.88x

PEG Ratio

BMEAN/A

CRBPN/A

Forward P/E (NTM)

BMEAN/A

CRBPN/A

Forward P/S (NTM)

BMEAN/A

CRBPN/A

Revenue (TTM)

BMEA$0

CRBP$0

Revenue Growth (YoY)

BMEAN/A

CRBPN/A

Forward Rev Growth

BMEA-19.3%

CRBP116.0%

Gross Margin (TTM)

BMEA0.0%

CRBP0.0%

Operating Margin (TTM)

BMEA0.0%

CRBP0.0%

EBITDA Margin (TTM)

BMEA0.0%

CRBP0.0%

Net Margin (TTM)

BMEA0.0%

CRBP0.0%

FCF Margin (TTM)

BMEAN/A

CRBPN/A

Net Income (TTM)

BMEA$-33M

CRBP$-102M

FCF (TTM)

BMEA$-47M

CRBP$-87M

EPS (TTM)

BMEA-$0.45

CRBP-$5.25

ROE (TTM)

BMEA-17119.0%

CRBP-8705.0%

ROA (TTM)

BMEA-6606.0%

CRBP-7422.0%

ROIC (TTM)

BMEA-17119.0%

CRBP-8705.0%

Cash

BMEA$35M

CRBP$23M

Debt

BMEA$0

CRBP$0

Net Cash/Debt

BMEA$35M

CRBP$23M

Current Ratio (TTM)

BMEA3.48x

CRBP5.71x

Quick Ratio (TTM)

BMEA3.36x

CRBP5.62x

Debt/Equity (TTM)

BMEA0.00x

CRBP0.00x

Debt/Assets (TTM)

BMEA0.0%

CRBP0.0%

Interest Coverage (TTM)

BMEAN/A

CRBPN/A

Net Debt/EBITDA (TTM)

BMEA0.00x

CRBP0.00x

Beta

BMEA-0.24

CRBP2.74

52W Performance

BMEA-15.5%

CRBP-59.9%

YTD Performance

BMEA6.0%

CRBP-31.6%

% from 52W High

BMEA-36.5%

CRBP-73.8%

% from 52W Low

BMEA62.9%

CRBP4.9%

Asset Turnover (TTM)

BMEA0.00x

CRBP0.01x

FCF Yield (TTM)

BMEA-46.0%

CRBP-87.0%

Earnings Yield (TTM)

BMEA-31.7%

CRBP-102.2%

Dividend Yield (TTM)

BMEAN/A

CRBPN/A

Rule of 40

BMEA0.0

CRBP0.0

EV/GP/RG

BMEAN/A

CRBPN/A

Ticker research

View BMEA research View CRBP research

Metric	BMEA Biomea Fusion Inc	CRBP Corbus Pharmaceuticals Holdings Inc
Market & Valuation
Market Cap	$103M	$100M
Enterprise Value	$68M	$76M
Price	$1.42	$5.38
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	76.49x
EV/Sales	0.00x	61.41x
EV/EBITDA	0.00x	0.00x
P/B Ratio	7.58x	1.16x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.44x	-0.88x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	-19.3%	116.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-33M	$-102M
FCF (TTM)	$-47M	$-87M
EPS (TTM)	-$0.45	-$5.25
ROE (TTM)	-17119.0%	-8705.0%
ROA (TTM)	-6606.0%	-7422.0%
ROIC (TTM)	-17119.0%	-8705.0%
Financial Health
Cash	$35M	$23M
Debt	$0	$0
Net Cash/Debt	$35M	$23M
Current Ratio (TTM)	3.48x	5.71x
Quick Ratio (TTM)	3.36x	5.62x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.24	2.74
52W Performance	-15.5%	-59.9%
YTD Performance	6.0%	-31.6%
% from 52W High	-36.5%	-73.8%
% from 52W Low	62.9%	4.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-46.0%	-87.0%
Earnings Yield (TTM)	-31.7%	-102.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BMEA research	View CRBP research